MARTINSRIED, Germany--(BUSINESS WIRE)--Proteros biostructures GmbH announced today that the first milestone of their research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography has been successfully achieved, triggering the associate milestone payment. In the collaboration, which started in June 2006, Proteros applies its target know-how, industrial process and proprietary Free Mounting System (FMSTM) and PicodropperTM technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs to Bayer HealthCare. Under the terms of the agreement Proteros will also receive a copy of the jointly selected fragment library for its own use.
